Literature DB >> 29770573

Looking into the eye of patients with chronic obstructive pulmonary disease: an opportunity for better microvascular profiling of these complex patients.

Anouk W Vaes1,2, Martijn A Spruit1,3,4, Jan Theunis2, Nandu Goswami5, Lowie E Vanfleteren1,3, Frits M E Franssen1,3, Emiel F M Wouters1,3, Patrick De Boever2,6.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a complex disease with many patients suffering from cardiovascular comorbidity. However, cardiovascular diseases remain often undiagnosed in COPD. Assessment of the retinal microvasculature can provide value in cardiovascular profiling of these patients. Retinal microvascular assessment carried out via a noninvasive eye exam represents an easy to use tool when examining patients with COPD. The purpose of this review was to provide an overview of studies assessing structural and functional changes in the retinal microvasculature of patients with COPD. Findings demonstrated that structural and functional microvascular changes were more common and severe in COPD patients as compared to non-COPD controls, although few retinal investigations have been performed in patients with COPD. As cardiovascular comorbidities are highly prevalent in COPD, we advocate more research to investigate the value of an eye exam for microvascular phenotyping of COPD patients.
© 2018 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cardiovascular disease; chronic obstructive pulmonary disease; colour Doppler ultrasonography; microvasculature; optical coherence tomography; retinal fundus imaging; retinal oximetry

Mesh:

Year:  2018        PMID: 29770573     DOI: 10.1111/aos.13765

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  7 in total

1.  Structural analysis of retinal blood vessels in patients with COPD during a pulmonary rehabilitation program.

Authors:  Anouk W Vaes; Martijn A Spruit; Karel Van Keer; João Barbosa-Breda; Emiel F M Wouters; Frits M E Franssen; Jan Theunis; Patrick De Boever
Journal:  Sci Rep       Date:  2020-01-08       Impact factor: 4.379

2.  Simple non-mydriatic retinal photography is feasible and demonstrates retinal microvascular dilation in Chronic Obstructive Pulmonary Disease (COPD).

Authors:  G J McKay; R V McCarter; R E Hogg; D H Higbee; M-P K Bajaj; D R Burrage; S Ruickbie; E H Baker; P W Jones; J W Dodd
Journal:  PLoS One       Date:  2020-01-10       Impact factor: 3.240

3.  The CT pulmonary vascular parameters and disease severity in COPD patients on acute exacerbation: a correlation analysis.

Authors:  Tao Yang; Chihua Chen; Zhongyuanlong Chen
Journal:  BMC Pulm Med       Date:  2021-01-20       Impact factor: 3.317

4.  Analysis of Retinal Blood Vessel Diameters in Pregnant Women Practicing Yoga: A Feasibility Study.

Authors:  Dejan Dinevski; Miha Lučovnik; Ivan Žebeljan; Domen Guzelj; Izidora Vesenjak Dinevski; Adam Salon; Patrick De Boever; Nandu Goswami
Journal:  Healthcare (Basel)       Date:  2022-07-21

5.  Assessment of the impact of HIV infection and anti-retroviral treatment on the cardiometabolic health of pregnant mothers and their offspring (ARTMOMSBABES).

Authors:  Benedicta Ngwenchi Nkeh-Chungag; Godwill Azeh Engwa; Charles Businge; Mziwohlanga Mdondolo; Magdevy Pajaro Medina; Nandu Goswami
Journal:  BMC Cardiovasc Disord       Date:  2021-06-30       Impact factor: 2.298

Review 6.  Biology of Lymphedema.

Authors:  Bianca Brix; Omar Sery; Alberto Onorato; Christian Ure; Andreas Roessler; Nandu Goswami
Journal:  Biology (Basel)       Date:  2021-03-25

7.  COVID-19 and its effects on endothelium in HIV-positive patients in sub-Saharan Africa: Cardiometabolic risk, thrombosis and vascular function (ENDOCOVID STUDY).

Authors:  Nandu Goswami; Per Morten Fredriksen; Knut E A Lundin; Chidozie Agu; Simiat Olanike Elias; Keolebogile Shirley Motaung; Bianca Brix; Gerhard Cvirn; Harald Sourij; Evelyn Stelzl; Harald H Kessler; Adam Salon; Benedicta Nkeh-Chungag
Journal:  BMC Infect Dis       Date:  2021-07-31       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.